If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

The future for GLP-1RA compounders, steps pharma can take in light of rising trial costs, funding ultra-rare therapies, and ...

A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic ...

The lawsuit accuses Willow of marketing and selling untested and unapproved compounded tirzepatide products, including "Tirzepatide Drops" and "Tirzepatide Plus," for cosmetic weight loss ...

From ‘Ozempic face’ to ‘Ozempic fingers’ and even ‘Wegovy butt,’ the potential side effects of weight loss medications have been well-documented. But now, a new study has revealed yet another ...

That came in response to a February lawsuit from a compounding trade group against the Food and Drug Administration's determination that the active ingredient in those drugs, semaglutide ...

inauthentic semaglutide drugs." Two weeks ago, Lilly sued an Indianapolis spa, Premier Weight Loss, claiming that it buys autoinjector pens filled with tirzepatide, cracks them open, breaking a ...

A federal judge April 24 rejected a bid by compounding pharmacies to continue selling less expensive copies of semaglutide ... loss and diabetes medication tirzepatide, sold under the brand ...

Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps reduce your appetite by influencing two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

70. Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy.